Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:35
’You’re here with us in spirit’: Sade Robinson memorial...
-
0:37
Day of the Dead celebrated at Zocalo Food Park
-
1:11
All aboard all train enthusiasts! Trainfest returns to Milwaukee...
-
0:57
’Spaghetti with the Sisters’ tradition serving up warm meals...
-
1:25
Quarry Lake at Harrington Beach State Park
-
4:39
’Death doesn’t need to be feared. It can be joyful’: Day...
-
2:12
As the clocks go back, we can move forward with some milder temperatures
-
0:33
Milwaukee Public Museum hosts first ever Powwow
-
3:36
‘Neighbors helping neighbors’: Milwaukee community stepping...
-
1:35
Thousands line up early Saturday at AmFam Field for We Energies...
-
1:24
Schlesinger’s Saturday Showcase (11/1)...Free Zoo Day, Beer...
-
2:12
November starting off on a cool, showery note
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.